info icon

Carcinoma in situ, other and unspecified urinary organs

CD2_INSITU_URINARY_NOS

No definition available.

Endpoint definition

FinnGen phenotype data

392423 individuals

diagram downward connector

Apply sex-specific rule None

392423

diagram downward connector

Check conditions None

392423

diagram downward connector
diagram bullet

Check pre-conditions, main-only, mode, registry filters

Hospital Discharge: ICD-10 D09.1&
Hospital discharge: ICD-9 2339
Cause of death: ICD-10 D09.1&
Cause of death: ICD-9 2339

2 out of 7 registries used, show all original rules.

15

diagram downward connector

Check minimum number of events None

15

diagram downward connector

Include endpoints None

15

diagram downward connector
diagram bullet diagram downward connector

Remove individuals based on genotype QC

15

diagram downward connector
CD2_INSITU_URINARY_NOS

Control definitions

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy 3
First used in FinnGen datafreeze DF2
Parent code in ICD-10 D09
Name in latin Carcinoma in situ organorum urinariorum aliorum sive non specificatorum

Similar endpoints

List of similar endpoints to Carcinoma in situ, other and unspecified urinary organs based on the number of shared cases.

Venn diagram with an highlighted set fully inside another set Broader endpoints:

Venn diagram with a set fully inside an highlighted set Narrower endpoints:

Show all endpoint correlations

Summary Statistics

Key figures

All Female Male
Number of individuals 15 8 7
Unadjusted prevalence (%) 0.00 0.00 0.00
Mean age at first event (years) 60.25 52.93 68.61

Mortality

Not a core endpoint, no data to show.

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Not a core endpoint, no data to show.

Correlations

Index endpoint: CD2_INSITU_URINARY_NOS – Carcinoma in situ, other and unspecified urinary organs
GWS hits:

Survival analyses between endpoints

Not a core endpoint, no data to show.

Drugs most likely to be purchased after Carcinoma in situ, other and unspecified urinary organs

Endpoint not on priority list, no data to show.